Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine patch adhesion in Parkinson's disease
2025-521172-64-00Phase 2Completed
- Sponsor
- Luye Pharma Group
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of rotigotine and rotigexole in Parkinson's disease (PD) (2 arms), sponsored by Luye Pharma Group. Primary endpoints: Mean adhesion of Test at 23 h 55 min and Difference of adhesiveness (Test – Reference) at 23 h 55 min. Started Jul 2025; status: completed.
02
Drugs
rotigotinerotigexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2025-521172-64-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521172-64-00.